Abstract
The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Current Molecular Medicine
Title: The Molecular Control of Antigenic Variation in Trypanosoma brucei
Volume: 4 Issue: 6
Author(s): David Horn
Affiliation:
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Abstract: The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Export Options
About this article
Cite this article as:
Horn David, The Molecular Control of Antigenic Variation in Trypanosoma brucei, Current Molecular Medicine 2004; 4 (6) . https://dx.doi.org/10.2174/1566524043360078
DOI https://dx.doi.org/10.2174/1566524043360078 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of Potential Pleiotropic Genes for Immune and Skeletal Diseases Using Multivariate MetaCCA Analysis
Current Genomics The Role of Macrophages in Rheumatoid Arthritis
Current Pharmaceutical Design Ectopic Lymphoid Neogenesis and Lymphoid Chemokines in Sjogren’s Syndrome: At the Interplay between Chronic Inflammation, Autoimmunity and Lymphomagenesis
Current Pharmaceutical Biotechnology Mixed Connective Tissue Disease (MCTD) and Undifferentiated Connective Tissue Disease (UCTD)
Current Rheumatology Reviews Double-Stranded RNA Induces MMP-9 Gene Expression in HaCaT Keratinocytes by Tumor Necrosis Factor-α
Inflammation & Allergy - Drug Targets (Discontinued) Emerging Cytokines in Allergic Airway Inflammation: A Genetic Update
Current Immunology Reviews (Discontinued) Gene Mining and Functional Genomics in Human Osteoarthritis
Current Genomics Cell Therapies for IBD: What Works?
Current Drug Targets Biotherapy for Autoimmune Liver Diseases
Current Pharmaceutical Biotechnology Radiosynthesis of 8-Fluoro-3-(4-[18F]Fluorophenyl)-3,4-Dihydro-1-Isoquinolinamine ([18F]FFDI), a Potential PET Radiotracer for the Inducible Nitric Oxide Synthase
Current Radiopharmaceuticals Technological Advances in Antigen Delivery and Synthetic Peptide Vaccine Developmental Strategies
Mini-Reviews in Medicinal Chemistry Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Potential Effect of Anti-Inflammatory Treatment on Reducing the Cardiovascular Risk in Rheumatoid Arthritis
Current Vascular Pharmacology Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
Anti-Cancer Agents in Medicinal Chemistry